Jeff Yass’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-117,400
| Closed | -$1.16M | – | 13747 |
|
|
2023
Q1 | $1.16M | Buy |
117,400
+28,100
| +31% | +$278K | ﹤0.01% | 6419 |
|
|
2022
Q4 | $890K | Buy |
89,300
+54,400
| +156% | +$406K | ﹤0.01% | 6436 |
|
|
2022
Q3 | $192K | Sell |
34,900
-7,500
| -18% | -$41.6K | ﹤0.01% | 10906 |
|
|
2022
Q2 | $155K | Buy |
42,400
+4,700
| +12% | +$22.2K | ﹤0.01% | 10990 |
|
|
2022
Q1 | $228K | Sell |
37,700
-13,200
| -26% | -$80.4K | ﹤0.01% | 10934 |
|
|
2021
Q4 | $429K | Buy |
50,900
+32,200
| +172% | +$281K | ﹤0.01% | 9579 |
|
|
2021
Q3 | $169K | Sell |
18,700
-7,400
| -28% | -$63.6K | ﹤0.01% | 11678 |
|
|
2021
Q2 | $211K | Sell |
26,100
-11,300
| -30% | -$77.5K | ﹤0.01% | 11497 |
|
|
2021
Q1 | $206K | Buy |
+37,400
| New | +$185K | ﹤0.01% | 11377 |
|
|
2015
Q3 | – | Sell |
-796
| Closed | -$17K | – | 10370 |
|
|
2015
Q2 | $17K | Buy |
796
+597
| +300% | +$59.1K | ﹤0.01% | 10013 |
|
|
2015
Q1 | $38K | Buy |
+199
| New | +$45.7K | ﹤0.01% | 9198 |
|
Jeff Yass's APEN Position: Q2 2023 in Review
Jeff Yass sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 420,511 shares — an estimated $4.17M sold.
Jeff Yass first reported a position in APEN in Q1 2014 and held it in 11 quarters. The position peaked at $4.17M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Jeff Yass reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Jeff Yass sold 420,511 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $4.17M.
- Jeff Yass first reported a position in Apollo Endosurgery, Inc. in Q1 2014 and held it in 11 quarters.
- Jeff Yass's Apollo Endosurgery, Inc. position peaked at $4.17M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.